Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results.

Published in:

Journal of Neurology, 2024, v. 271, n. 8, p. 5402, doi. 10.1007/s00415-024-12470-6

By:

• Gantenbein, Andreas R.;
• Bonvin, Christophe;
• Kamm, Christian P.;
• Schankin, Christoph J.;
• Zecca, Chiara;
• Zieglgänsberger, Dominik;
• Merki-Feld, Gabriele Susanne;
• Pohl, Heiko;
• Rudolph, Nicole;
• Ryvlin, Philippe;
• Agosti, Reto;
• Schäfer, Elisabeth;
• Meyer, Ina;
• Kulartz-Schank, Monika;
• Arzt, Michael E.

Publication type:

Article